Twist Bioscience Corporation (TWST) Revenue by Segment
Twist Bioscience revenue by segment at a glance
In Q1 fiscal 2021 (the quarter ended December 31, 2020), Twist Bioscience's largest business segment was Health Care, with $15.98 million or 57% of revenue, up 173.8% from a year earlier. Next: Industrial Chemicals (25%), Academic Research (17%) and Food Or Agriculture (1%).
By product or service, Ngs Tools brought in 52% and Antibody Discovery brought in 48% of revenue in Q3 fiscal 2026.
By region, Americas brought in 65%, EMEA brought in 28% and Asia Pacific brought in 6% of revenue in Q3 fiscal 2026.
The fastest-growing business segment from a year earlier was Health Care (+173.8%).
From company filings, in USD; latest quarter ended December 31, 2020; quarterly data from Q1 fiscal 2018.
Twist Bioscience Corporation
Revenue breakdown
Fiscal quarters, from company filings
Twist Bioscience revenue by business segment, last 4 quarters
| Business segment | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Share |
|---|---|---|---|---|---|
| Health Care | – | – | – | – | 57% |
| Industrial Chemicals | – | – | – | – | 25% |
| Academic Research | – | – | – | – | 17% |
| Food Or Agriculture | – | – | – | – | 1% |
In USD, fiscal quarters as reported; share = part of Q1 FY21 revenue.
Twist Bioscience revenue by product or service, last 4 quarters
| Product or service | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Share |
|---|---|---|---|---|---|
| Ngs Tools | $61.8M | $57.4M | $52.6M | $55.3M | 52% |
| Antibody Discovery | $56.6M | $53.3M | $51.1M | $40.8M | 48% |
In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.
Twist Bioscience revenue by region, last 4 quarters
| Region | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Share |
|---|---|---|---|---|---|
| Americas | $77.3M | $64.3M | $58.4M | $59.4M | 65% |
| EMEA | $33.6M | $37.3M | $38.4M | $30.7M | 28% |
| Asia Pacific | $7.5M | $9.1M | $7.0M | $5.9M | 6% |
In USD, fiscal quarters as reported; share = part of Q3 FY26 revenue.
Questions and answers
What are Twist Bioscience's business segments?
Health Care, Industrial Chemicals, Academic Research and Food Or Agriculture (as reported for Q1 fiscal 2021).
Which business segment makes the most money for Twist Bioscience?
Health Care: $15.98 million, or 57% of revenue, in Q1 fiscal 2021.
What are Twist Bioscience's main products and services?
By revenue in Q3 fiscal 2026: Ngs Tools (52%) and Antibody Discovery (48%).
Where does Twist Bioscience make its money?
By region in Q3 fiscal 2026: Americas (65%), EMEA (28%) and Asia Pacific (6%).
